FDA Inspection 1052727 — DAKOTA DRUG
The FDA completed an inspection of DAKOTA DRUG on Apr 11, 2018 in Anoka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 11, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Anoka, MN (United States)